SASergey E. Arakelov

Sergey E. Arakelov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sergey E. Arakelov has a total of 97 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prediction of the post-hospital complications in patients with decompensated chronic heart failure

    by V. N. Larina, I. K. Skiba, A. V. Skiba, S. E. Arakelov, В. Н. Ларина, И. К. Скиба, А. В. Скиба, С. Э. Аракелов

    Aim . To evaluate the value of the left ventricular global function index (LVGFI) for predicting readmissions and death within 1 year after inpatient treatment for acute decompensated heart failure (ADHF). Material and methods . The study included 100 patients (51% men) aged 73.8±7.5 years hospitalised for ADHF. Follow-up lasted 12 months; the primary composite endpoint was readmission for ADHF and/or posthospital death. All patients underwent a medical history and physical examination, laboratory tests, a six-minute walk test after stabilization, and transthoracic echocardiography with subsequent calculation of the LVGFI. Results . During the follow-up period, 40 patients achieved the primary endpoint (35 patients had readmissions for ADHF alone, and 5 patients had readmissions and death due to ADHF). Based on the outcome, patients were divided into 2 groups: those with readmissions and/or death and those without adverse events. Significant differences were found between the groups in LVGFI (pConclusion . An LVGFI value of <12.6% can be considered a significant predictor of adverse outcomes (rehospitalisation and/or death) during the first year of post hospitalisation in patients who have experienced an episode of ADHF. Using LVGFI may facilitate more accurate posthospital risk stratification and identify the most vulnerable group of patients requiring more intensive monitoring and optimisation of therapy after discharge.

  • Open Access

    Clinical effects of hyperbaric oxygenation in the treatment of ischemic heart disease

    by К. V. Glibko, К. M. Polyakov, P. Ya. Skovran, S. E. Arakelov, N. V. Orlova, К. В. Глибко, К. М. Поляков, П. Я. Сковран, С. Э. Аракелов, Н. В. Орлова

    Hyperbaric oxygenation (HBO) is used in combination therapy for various diseases. HBO increases oxygen delivery to tissues, improves angiogenesis, and prevents thrombus formation. The aim of the study was to investigate the effects of HBO in patients with ischemic heart disease. The study included 40 patients with ischemic heart disease (IHD). The treatment course included standard therapy for ischemic heart disease in accordance with the Clinical Guidelines, as well as HBO using “mild” modes (1.4/55 and 1.5/55 ATA) with the BLKS 303MK device. No adverse events were observed in the patients during the HBO course. During the HBO course, no adverse events were observed in the patients. The use of HBO in treating patients is accompanied by a reduction in inflammatory activity and oxidative stress, normalization of carbohydrate metabolism, and an increase in HDL. The survey results showed a positive effect of HBO on the cognitive functions, psychological status, and physical status of the patients: the proportion of patients with normal cognitive functions increased from 30 % to 97.5 %; the severity of anxiety and depression according to the HADS scale decreased; the frequency of subclinical anxiety and subclinical depression, as well as the intensity of pain, decreased. According to the SF36, physical functioning, overall health status, social functioning, and the physical component of health improved statistically significantly; the total SF36 score increased from 85.2 (77.2–92.4) to 91.5 (84.5–95) points (p<0.001). Tolerance to physical exertion increased: the distance covered in the 6minute walk test increased from 400 (350–400) to 428 (400–450) m (p < 0.001).

  • Open Access

    NATIVE T1 mapping and liver and splenic extracellular volume fraction in the stratification of liver cirrhosis according to Child-Pugh classes: a retrospective study

    by Yu. N. Savchenkov, G. E. Trufanov, V. A. Fokin, E. A. Ionova, A. P. Savchenkova, V. A. Prosikov, S. E. Arakelov

    INTRODUCTION: Liver cirrhosis represents the end stage of chronic liver diseases and is associated with the development of portal hypertension, leading to alterations in quantitative magnetic resonance (MR) parameters of the liver and spleen. Noninvasive techniques, including native T1 mapping and extracellular volume fraction (ECV) calculation, are considered promising tools for disease severity stratification; however, their comparative diagnostic performance in classifying patients according to the Child-Pugh grading system remains insufficiently investigated. OBJECTIVE: To evaluate and compare the diagnostic performance of native T1 mapping and liver and splenic extracellular volume fraction for stratifying liver cirrhosis according to Child-Pugh classes. MATERIALS AND METHODS: This retrospective study included 50 patients with confirmed liver cirrhosis who underwent multiparametric magnetic resonance imaging (MRI) with native T1 mapping (MOLLI 4(1)3(1)2 and 5(3)3 protocols) and calculation of liver and spleen extracellular volume fraction (ECV). Patients were stratified according to Child-Pugh classes: A (n=31), B (n=13), and C (n=6). Statistics: Intergroup analysis was performed using the Kruskal-Wallis and Mann-Whitney tests with Benjamini-Hochberg correction (FDR), along with Spearman correlation analysis and ROC analysis with calculation of the area under the curve (AUROC) and pairwise comparison of ROC curves using the DeLong test. RESULTS: Statistically significant intergroup differences were observed for all quantitative MRI parameters (p≤0.002; FDR DISCUSSION: The findings indicate higher specificity of liver ECV compared with integral native T1 mapping parameters in reflecting the functional severity of cirrhosis according to the Child-Pugh classification. Spleen ECV primarily reflects hemodynamic manifestations of portal hypertension and is less closely associated with progression of hepatocellular insufficiency. CONCLUSION: Liver ECV is the most accurate and informative quantitative MR parameter for stratifying cirrhosis according to Child-Pugh classes, outperforming native liver T1 mapping, spleen ECV, and spleen T1 mapping in diagnostic value.

  • Open Access

    Atrial fibrillation paroxysm as a mask of thyrotoxicosis in an elderly patient: Diagnostic features and the role of hidden causes

    by O. U. Fatima, S. E. Arakelov, M. M. Omarova, Ф. О. Ушанова, С. Э. Аракелов, Марин Мусаевна Омарова

    Atrial fibrillation paroxysm as a mask of thyrotoxicosis in an elderly patient: Diagnostic features and the role of hidden causes | Fatima | FOCUS. Endocrinology Пароксизм фибрилляции предсердий как маска тиреотоксикоза у пожилого пациента: особенности диагностики и роль скрытых причин | Ушанова | FOCUS Эндокринология

  • Open Access

    Cardiorenal metabolic syndrome: A clinical case of a multimorbid patient and rationale for cardio- and nephroprotective therapy

    by M. Ya. Izmailova, S. E. Arakelov, V. E. Bairova, K. R. Busel, М. Я. Измайлова

    Кардио-рено-метаболический синдром: мультиморбидный пациент и стратегия кардио- и нефропротекции

  • Diagnostic Effectiveness of Native T1 Mapping in Staging Liver Fibrosis According to Magnetic Resonance Imaging

    by Yu. N. Savchenkov, G. E. Trufanov, V. A. Fokin, E. A. Ionova, S. E. Arakelov, O. V. Bodrova

    Background. Liver fibrosis represents a structural manifestation of chronic liver diseases and, with progression, leads to the development of cirrhosis and related complications. Native liver T1 mapping is considered a quantitative magnetic resonance imaging (MRI) technique reflecting the severity of fibrotic changes; however, its diagnostic performance may be influenced by liver tissue composition, including steatosis. Objective : to evaluate the diagnostic performance of native T1 mapping for liver fibrosis staging and to assess the impact of steatosis on its diagnostic characteristics. Material and methods . This retrospective study included 241 patients who underwent abdominal MRI with acquisition of native liver T1 relaxation maps using the MOLLI 4(1)3(1)2 and MOLLI 5(3)3 protocols with pulse-triggered cardiac synchronization during a single breath-hold. Reference fibrosis staging (METAVIR F0–F4) was established based on integrated clinical, laboratory, and instrumental data. An additional stratification was performed according to the presence of hepatic steatosis, determined based on proton density fat fraction values. Patients with evidence of hepatic iron overload were excluded from the analysis. The relationship between native liver T1 values and fibrosis stage was assessed using correlation analysis, and intergroup comparisons were performed across fibrosis stages. Diagnostic performance was evaluated using receiver operating characteristic (ROC) analysis for the identification of clinically significant fibrosis (≥F2), advanced fibrosis and cirrhosis (≥F3), and cirrhosis (F4). Statistical analysis was performed using nonparametric methods. Multiple comparisons were controlled using the Benjamini–Hochberg procedure, and results were considered statistically significant at false discovery rate (FDR) Results. A statistically significant positive correlation was observed between native liver T1 values and fibrosis stage (ρ=0.779 for MOLLI 4(1)3(1)2 and ρ=0.792 for MOLLI 5(3)3; pConclusion . Native liver T1 mapping using MOLLI 4(1)3(1)2 and MOLLI 5(3)3 protocols is an informative quantitative MRI technique for fibrosis staging. Diagnostic performance increases from ≥F2 to ≥F3 and reaches its highest level in cirrhosis. The presence of steatosis reduces discriminatory performance for ≥F2, thereby defining the limitations of the technique and supporting its use as part of a multiparametric MRI approach in patients with chronic liver diseases.

  • Open Access

    Cardiorenal syndrome in an 85-year-old patient with neurofibromatosis. Case report

    by Elena V. Reznik, Tatiana A. Gaydina, Evgeniya A. Koltsova, Dmitry V. Gornostaev, Sergey V. Shigeev, Yuri Yu. Golubev, Natalia V. Yurtaeva, Galina Yu. Ishchenko, Sergey E. Arakelov, Гайдина Татьяна Анатольевна, et al.

    Neurofibromatosis (NF) is a hereditary disease characterized by the formation and growth of benign tumors of neuroectodermal origin. There are three main nosological forms: NF1, NF2, NF3. It is believed that the disease debuts in childhood and significantly reduces the life expectancy of patients. The main cause of death in middle age are cardiovascular diseases and malignant neoplasms. There are isolated publications on NF in patients over 60 years old. The relationship between NF and cardiorenal syndrome has not been sufficiently studied. The development of vasculitis with vasculopathy is described, which leads to narrowing and occlusion of the coronary, renal, cerebral and other arteries. The article presents a description of an 85-year-old patient with NF and the development of cardiorenal syndrome.

  • Open Access

    Drug-induced Brugada syndrome: Case report

    by Yuri N. Fedulaev, Irina V. Makarova, Fatima G. Magomedova, Sergey E. Arakelov, Irina Yu. Titova

    Brugada syndrome (BrS) is an inherited clinical and electrocardiographic syndrome, related to ion channelopathies and associated with an increased risk of sudden cardiac death. The cornerstone in diagnosis remains a spontaneous type 1 Brugada-pattern on the electrocardiogram (ECG), including J point elevation of ≥ 2 mm, coved-type ST segment elevation and T wave inversion in right precordial leads. Similar ECG changes, induced by antiarrhythmic therapy, should be considered as diagnostic when combined with a documented polymorphic ventricular tachycardia or ventricular fibrillation episode, arrhythmogenic syncope, nocturnal agonal breathing or a family history of sudden cardiac death or BrS. The article represents a clinical case of drug-induced type 1 Brugada-pattern in the settings of antiarrhytmic treatment using 1C class sodium channel blocker ethacizine in a female without additional BrS criteria, with negative genetic testing results and the ECG normalization after drug withdrawal.

  • Quality of life of patients with inguinal hernias after laparoscopic transabdominal preperitoneal hernioplasty using anatomically adapted implants

    by S.V. Kharitonov, G.V. Rodoman, S.E. Arakelov, S.S. Kharitonov, G.A. Petrosyan, M.S. Kaschieva

    Objective. Assessment of quality of life (QOL) of patients with primary inguinal hernias after laparoscopic transabdominal preperitoneal hernioplasty (TAPP) using anatomically adapted implants. Material and methods. The prospective controlled clinical study included the results of treatment of 72 patients. The main group consisted of patients in whom lightweight polypropylene implants with a volumetric anatomically adapted spatial structure were used TAPP hernioplasty. Patients in the control group underwent TAPP with lightweight flat polypropylene meshes, fixed with a hernia stapler. Quality of life were studied in patients using the SF-36 questionnaire in the preoperative period and 3, 6 and 12 months after surgery. Results. 3 months after TAPP, the change in the quality of life indicators of patients using anatomically adapted implants for plastic surgery was accompanied by a significant increase and almost complete restoration of the physical and psychological components of health of the operated patients. Similar values of quality of life indicators at these observation periods were also revealed when using classic endoprostheses with stapler fixation. 6 and 12 months after TAPP, the quality of life indicators of both groups of patients did not undergo any significant changes and did not differ significantly from each other. The only feature of these observation stages was the registration of a statistically significant difference in the mental health indicator, which in patients with anatomically adapted implants 6 months after plastic surgery slightly exceeded the indicator of patients in the comparison group. Conclusion. The use of anatomically adapted implants when performing TAPP in patients with primary inguinal hernias is accompanied by recovery times for quality of life indicators in operated patients comparable to those of stapler fixation of classical endoprostheses, which allows them to be recommended for plastic surgery of the anterior abdominal wall in patients with primary inguinal hernias.